Suppr超能文献

原位胫骨重建:是前沿技术还是一时风尚?

In situ tibial reconstruction. State-of-the-art or passing fancy.

作者信息

Buchbinder D, Rollins D L, Semrow C M, Schuler J J, Meyer J P, Flanigan D P

机构信息

Department of Surgery, University of Health Sciences, Chicago Medical School, Illinois 60064.

出版信息

Ann Surg. 1988 Feb;207(2):184-8. doi: 10.1097/00000658-198802000-00012.

Abstract

To further evaluate the efficacy of in situ saphenous vein bypass, the authors have reviewed their experience with in situ bypass. Between October 1981 and December 1985, 120 in situ saphenous vein bypass were performed; 81 were to infrapopliteal vessels. All procedures were performed for limb salvage. The mean patient age was 74 years, and 74% were men, 57% had diabetes mellitus, 92% were smokers, and 72% had hypertension and/or coronary artery disease. All patients were evaluated by preoperative noninvasive testing and biplanar angiography. All procedures were performed by the valve incision technique. The vein utilization rate was 91%. Grafts were routinely placed into isolated tibial segments and foot vessels without evidence of a patent pedal arch. Follow-up information was obtained at 3-month intervals. Patency and limb salvage data were calculated by life-table analysis. The cumulative patency rates were 98% at 1 month, 88% at 12 months, and 82% at 50 months. These data demonstrate that the in situ bypass maintains an excellent patency rate and provides durable limb salvage.

摘要

为进一步评估原位大隐静脉搭桥术的疗效,作者回顾了他们开展原位搭桥术的经验。在1981年10月至1985年12月期间,共进行了120例原位大隐静脉搭桥术;其中81例是针对腘动脉以下血管。所有手术均为保肢目的而进行。患者平均年龄为74岁,74%为男性,57%患有糖尿病,92%为吸烟者,72%患有高血压和/或冠状动脉疾病。所有患者术前均接受无创检查和双平面血管造影评估。所有手术均采用瓣膜切开技术。静脉利用率为91%。移植物常规植入孤立的胫段和足部血管,无足背动脉弓通畅的证据。每3个月获取一次随访信息。通过寿命表分析计算通畅率和保肢数据。1个月时的累积通畅率为98%,12个月时为88%,50个月时为82%。这些数据表明,原位搭桥术保持了极高的通畅率,并能持久地挽救肢体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8042/1493385/f51e61f778c1/annsurg00192-0081-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验